News Focus
News Focus
Followers 14
Posts 1443
Boards Moderated 0
Alias Born 04/07/2019

Re: shadolane post# 398689

Wednesday, 01/18/2023 7:03:17 PM

Wednesday, January 18, 2023 7:03:17 PM

Post# of 447443
And I agree with you and others. R-It was a long and expensive trial with amazing results. We, & Amarin have been quagmired since the Du decision. So, all I am saying is any additional positive news has to put us in a better place than we currently sit.
Amarin C-Suite and BOd have benefitted but not the shareholders and I am pissed that they continue to award themselves options and RSU's for NO positive results.
Somehow this drug has to begin it's upward trajectory and any additional good news from Mitigate, Brave, etc. will (should) benefit.
Bring on Denner to move us forward. I don't have a 2-5 year window for this to drag out.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News